Overexpression of placental leptin in diabetic pregnancy - A critical role for insulin

被引:178
作者
Lepercq, J
Cauzac, M
Lahlou, N
Timsit, J
Girard, J
Auwerx, J
Hauguel-de Mouzon, S
机构
[1] CNRS UPR 1524, F-92190 Meudon, France
[2] Hop St Vincent de Paul, Serv Gynecol Obstet, F-75674 Paris, France
[3] Hop St Vincent de Paul, INSERM U342, F-75674 Paris, France
[4] Hop Necker Enfants Malad, Serv Immunol Clin, Paris, France
[5] Inst Pasteur, Lab Biol Regulat Chez Eucaryotes, F-59019 Lille, France
关键词
D O I
10.2337/diabetes.47.5.847
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Leptin, a small peptide produced by adipocytes, is implicated in an increasing number of endocrine regulations, including adiposity, satiety, puberty, and fertility. Although the factors involved in controlling maternal and fetal weight gain during pregnancy have not been fully elucidated, leptin has recently emerged as such a potential factor. In our study, we report the presence of high amounts of leptin mRNA and immunoreactive protein in the human placenta, establishing the placental synthesis of this hormone. A large (three-to fivefold) augmentation in leptin mRNA and protein was found in placentas from insulin-treated diabetic women. This finding was associated with increased concentrations of leptin and insulin in venous cord blood without modification of maternal circulating leptin levels, These data provide evidence that the placenta is a site for regulated leptin production in utero, Insulin is likely to play a critical role in this regulation, thus emphasizing the importance of placental leptin signaling in diabetic pregnancy.
引用
收藏
页码:847 / 850
页数:4
相关论文
共 30 条